← Leaderboards
Michael Sejr Vajdy
Epitogenesis, Inc.
$585,600
Attributed
$885,600
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $300K · FY2009–13$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$885,600 · 2
By mechanism
R41$600,000 · 1
R43$285,600 · 1
Top collaborators
- Deborah Anne Dean2 shared
Others in their field
Top investigators on “Immunogenicity”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$489,963,650
- Lawrence Corey · Fred Hutchinson Cancer Center$378,262,806
- Barton F Haynes · Duke University$364,422,244
- Dennis R. Burton · Scripps Research Institute$311,593,259
- Peter B. Gilbert · Fred Hutchinson Cancer Center$200,471,907
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$172,054,560
Research focus
ImmunogenicityResponseImmuneImmunizationInfectionProtective EfficacyEpithelial CellsHiv-1DesignImmunityAntibody FormationCellsLeadMucous MembraneBaseDrug FormulationsAntigen-Presenting CellsFlavonoidsCommon Iliac Lymph NodeAntigensCatechinImmune ResponseCytokineRoute
Grant awards (4)
A novel vaccine against vaginal Chlamydia trachomatis$300,000
R41 · FY2013 · AI · contact PI
A novel vaccine against vaginal Chlamydia trachomatis$300,000
R41 · FY2012 · AI · contact PI
Mucosal Immune-enhancing Delivery System for HIV vaccines$145,600
R43 · FY2010 · AI · contact PI
Mucosal Immune-enhancing Delivery System for HIV vaccines$140,000
R43 · FY2009 · AI · contact PI